-
1دورية أكاديمية
المؤلفون: Seleme VB; Cardiology-Arterial Hypertension Department, Hospital de Clinicas from Universidade Federal do Parana (HC/UFPR), General Carneiro, 181, Curitiba, Paraná, 80060-900, Brazil. viniciusbseleme@yahoo.com.br.; Positivo University, R. Prof. Pedro Viriato Parigot de Souza, 5300, Curitiba, Paraná, Brazil. viniciusbseleme@yahoo.com.br., Marques GL; Cardiology-Arterial Hypertension Department, Hospital de Clinicas from Universidade Federal do Parana (HC/UFPR), General Carneiro, 181, Curitiba, Paraná, 80060-900, Brazil., Mendes AEM; Cardiology-Arterial Hypertension Department, Hospital de Clinicas from Universidade Federal do Parana (HC/UFPR), General Carneiro, 181, Curitiba, Paraná, 80060-900, Brazil., Rotta I; Cardiology-Arterial Hypertension Department, Hospital de Clinicas from Universidade Federal do Parana (HC/UFPR), General Carneiro, 181, Curitiba, Paraná, 80060-900, Brazil., Pereira M; Department of Cardiology, Hospital Nossa Senhora das Graças, Alcides Munhoz, 433, Curitiba, Paraná, 80810-040, Brazil., Júnior EL; Cardiology-Arterial Hypertension Department, Hospital de Clinicas from Universidade Federal do Parana (HC/UFPR), General Carneiro, 181, Curitiba, Paraná, 80060-900, Brazil., da Cunha CLP; Cardiology-Arterial Hypertension Department, Hospital de Clinicas from Universidade Federal do Parana (HC/UFPR), General Carneiro, 181, Curitiba, Paraná, 80060-900, Brazil.
المصدر: American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2021 Mar; Vol. 21 (2), pp. 165-180.
نوع المنشور: Journal Article; Meta-Analysis; Systematic Review
بيانات الدورية: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100967755 Publication Model: Print Cited Medium: Internet ISSN: 1179-187X (Electronic) Linking ISSN: 11753277 NLM ISO Abbreviation: Am J Cardiovasc Drugs Subsets: MEDLINE
مواضيع طبية MeSH: Antihypertensive Agents/*therapeutic use , Hypertension/*drug therapy , Nebivolol/*therapeutic use, Adolescent ; Adrenergic beta-Antagonists/therapeutic use ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Calcium Channel Blockers/therapeutic use ; Diabetes Mellitus/epidemiology ; Diuretics/therapeutic use ; Double-Blind Method ; Drug Therapy, Combination ; Female ; Humans ; Hypertension/epidemiology ; Male ; Middle Aged ; Multicenter Studies as Topic ; Randomized Controlled Trials as Topic ; Sex Factors ; Socioeconomic Factors ; Young Adult